Cargando…
Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells
BACKGROUND: Targeted co-delivery of siRNA and a chemotherapeutic drug is an attractive approach to cancer drug design and treatment. This study was carried out to design an anti-Mucin1 aptamer (Apt)-conjugated chitosan nanoparticle (NP) for targeted co-delivery of insulin-like growth factor receptor...
Autores principales: | Jafari, Reza, Zolbanin, Naime Majidi, Majidi, Jafar, Atyabi, Fatemeh, Yousefi, Mehdi, Jadidi-Niaragh, Farhad, Aghebati-Maleki, Leili, Shanehbandi, Dariush, Zangbar, Mohammad-Sadegh Soltani, Rafatpanah, Houshang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305820/ https://www.ncbi.nlm.nih.gov/pubmed/30041514 http://dx.doi.org/10.29252/.23.1.21 |
Ejemplares similares
-
Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells
por: Majidi Zolbanin, Naime, et al.
Publicado: (2018) -
Immuno-biosensor for Detection of CD20-Positive Cells Using Surface Plasmon Resonance
por: Shanehbandi, Dariush, et al.
Publicado: (2017) -
Phage display as a promising approach for vaccine development
por: Aghebati-Maleki, Leili, et al.
Publicado: (2016) -
A methodological approach for production and purification of polyclonal antibody against dog IgG
por: Sadeghi, Somayeh, et al.
Publicado: (2018) -
Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine
por: Nikfarjam, Sepideh, et al.
Publicado: (2020)